Center for Inherited Disease Research (CIDR)
What is CIDR?
The Center for Inherited Disease Research (CIDR) Program at The Johns Hopkins University provides high-quality next generation sequencing and genotyping services to investigators working to discover genes that contribute to common diseases.
The NIH CIDR Program
Thirteen Institutes at the NIH support a contract with CIDR that offers investigators access to next-generation sequencing, genotyping, and statistical genetics services at a reduced cost. Requests for services are evaluated using a competitive, peer-reviewed application process.
Applying for CIDR Services as an NCI Grantee
Researchers who have submitted (or plan to submit) a parent grant application to NCI may request CIDR services, via the NIH contract, after they have obtained clearance from NCI. (Researchers with grant applications funded by other NIH Institutes should obtain instructions specific to that Institute by contacting the appropriate CIDR Program Liaison.)
Investigators can obtain clearance from NCI by emailing the NCI CIDR Liaison, Melissa Rotunno, with the following information:
- The intended date of submission of the CIDR application and of the related parent grant application
- The abstract and specific aims of the proposed CIDR application and of the related parent grant application (NOTE: The genotyping or sequencing services requested must be relevant to the NCI parent grant application)
- The type of genotyping or sequencing platform requested
- The number and type of samples to be included for genotyping or sequencing
Once clearance has been granted by the NCI CIDR Liaison, applications must be submitted electronically through Grants.gov using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide. Access to the CIDR Program is awarded using the X01 grant award mechanism. CIDR applications are accepted continuously and are reviewed six times per year. For more information about the NIH CIDR application process, visit the CIDR website or contact Camilla Day, the CIDR Liaison for NIH.
Please note: Investigators can apply for access to CIDR before submitting an NIH parent grant application. If access is granted, a letter verifying CIDR's commitment to perform the genotyping will be sent to the applicant for inclusion in a parent grant application, however CIDR access will be contingent on the parent grant being funded.
- CIDR Liaison for NIH – Barbara Thomas, Ph.D., National Human Genome Research Institute, Division of Extramural Operations, Scientific Review Branch
- CIDR Liaison for NCI – Melissa Rotunno, Ph.D., National Cancer Institute (NCI), Division of Cancer Control and Population Sciences, Epidemiology and Genomics Research Program